Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4115947-A4115947, November 12, 2024. Background:The positive effects of sodium glucose co-transporter-2 (SGLT2) inhibitors on reducing cardiovascular mortality and hospitalizations due to heart failure have been well established.

Heart Failure 40

Heart Failure Cardiac Function Myocardial Infarction Aortic 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139191-A4139191, November 12, 2024. Introduction:Heart failure with reduced ejection fraction (HFrEF) remains a significant clinical challenge, evidenced by high hospitalization rates and five-year mortality. Cardiac function was assessed by echocardiography at 2-, 4- and 6-weeks post-MI.

Myocardial Infarction 40

Myocardial Infarction Heart Failure Cardiac Function Biomarkers 40

Circulation: Heart Failure

FEBRUARY 1, 2024

Circulation: Heart Failure, Ahead of Print. Background:NT-proBNP (N-terminal pro-B-type natriuretic peptide) levels are variably elevated in heart failure with preserved ejection fraction (HFpEF), even in the presence of increased left ventricular filling pressures.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Atrial Fibrillation Cardiac Function 40

Circulation: Cardiovascular Interventions

NOVEMBER 9, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Background:There are limited data about changes in cardiac function (cardiac reverse remodeling) and heart failure indices after transcatheter tricuspid valve-in-valve replacement (TT-VIVR).

Congenital Heart Disease 40

Congenital Heart Disease Tricuspid Heart Failure Congenital 40

Circulation: Genomic and Precision Medicine

JANUARY 30, 2024

Circulation: Genomic and Precision Medicine, Ahead of Print. BACKGROUND:Pathogenic variants in PKP2 (plakophilin-2) cause arrhythmogenic right ventricular cardiomyopathy, a disease characterized by life-threatening arrhythmias and progressive cardiomyopathy leading to heart failure.

Cardiomyopathy 72

Cardiomyopathy Arrhythmia Cardiac Function Heart Failure 72

Circulation

NOVEMBER 14, 2023

Circulation, Ahead of Print. BACKGROUND:Cardiac metabolic dysfunction is a hallmark of heart failure (HF). Estrogen-related receptors ERRα and ERRγ are essential regulators of cardiac metabolism. We investigated the effect of ERR agonist on cardiac function in a pressure overload–induced HF model in vivo.

Heart Failure 40

Heart Failure Pharmacology Cardiac Function Circulation 40

Circulation: Heart Failure

NOVEMBER 8, 2024

Circulation: Heart Failure, Volume 17, Issue 12 , Page e011729, December 1, 2024. Cardiac function was measured by echocardiography. In EAM, the treatment prevented deterioration of cardiac function, measured on day 42 post-disease induction (left ventricular ejection fraction: 56.5% versus 51.0%

Cardiac Function 40

Cardiac Function Heart Failure Circulation 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4145572-A4145572, November 12, 2024. Introduction:Dilated cardiomyopathy (DCM) is one of the causative diseases of heart failure, caused by genetic mutations. However, the method to reduce DNA damage in the heart has not been elucidated.

Cardiomyopathy 40

Cardiomyopathy Cardiac Function Heart Failure Circulation 40

DAIC

APRIL 30, 2024

Since mammals cannot regenerate cardiac muscle cells on their own, heart transplants are currently the only clinically viable option for patients suffering (or likely to suffer) heart failure. They monitored the condition of the animals for twelve weeks, taking regular measurements of cardiac function.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

DAIC

DECEMBER 12, 2023

The damage to the heart muscle is usually permanent, leaving the heart unable to pump the way it should. That’s the subject of a new study by a team that includes two USF Health doctors who reported their findings in Circulation , the flagship journal of the American Heart Association. “An

Heart Attack 105

Heart Attack Heart attacks Heart Disease Pharmacology 105

DAIC

MARCH 20, 2024

Getty Images milla1cf Wed, 03/20/2024 - 19:16 March 20, 2024 — SARS-CoV-2 , the virus that causes COVID-19 , can damage the heart even without directly infecting the heart tissue, a National Institutes of Health -supported study has found.

COVID-19 105

COVID-19 Heart Attack Heart attacks Research 105

Journal of Cardiovascular Pharmacology

JULY 23, 2024

Although the mineralocorticoid-receptor antagonist spironolactone, in conjunction with renin-angiotensin system (RAS) inhibitors, has been shown to reduce mortality in patients with heart failure with reduced ejection fraction (HFrEF), its efficacy in managing degenerative MR is uncertain.

Bicuspid/Mitral 40

Bicuspid/Mitral Cardiac Function Heart Failure Circulation 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4146466-A4146466, November 12, 2024. Background:Without timely intervention, pressure-overloading left ventricular (poLV) remodeling may become progressive and readily degenerate into heart failure.

Congenital Heart Disease 40

Congenital Heart Disease Heart Failure Transplant Pediatrics 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4140419-A4140419, November 12, 2024. Cardiac fibrosis is a pathological hallmark of almost all forms of heart disease, characterized by excessive deposition of extracellular matrix (ECM) proteins by activated fibroblasts, leading to cardiomyocyte hypertrophy, arrhythmias, and heart failure.

Cardiac Function 40

Cardiac Function Pharmacology Innovation Heart Failure 40

Circulation: Heart Failure

FEBRUARY 27, 2024

Circulation: Heart Failure, Ahead of Print. BACKGROUND:Exercise training can promote cardiac rehabilitation, thereby reducing cardiovascular disease mortality and hospitalization rates. Quantitative real-time polymerase chain reaction was used to detect the expression levels of miR-574-3p and cardiac hypertrophy markers.

Exercise 40

Exercise Cardiac Rehabilitation Cardiac Function Heart Failure 40

Cardiomatics

FEBRUARY 9, 2022

One of these diseases is heart failure – a condition in which the heart is unable to pump enough blood to the organs in our body. This results in a deficiency of oxygen and nutrients in the cells of the body, which can have a huge impact on how it functions. Heart Fail. Circulation 2010, 122, 2022–2030. [6]

Heart Failure 52

Heart Failure Myocardial Infarction Medicare Defibrillator 52

DAIC

FEBRUARY 18, 2025

The multisociety working group defined five outcome domains: vital status, patient-reported outcomes, progression of the disease, cardiac function and durability, and complications of treatment. tim.hodson Tue, 02/18/2025 - 16:41 Feb.

Heart Valves 52

Heart Valves Quality of Life Cardiothoracic Outcomes 52

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4115027-A4115027, November 12, 2024. Background:The emerging field of cardiac optogenetics uses pulses of light to stimulate optically-sensitive proteins in the heart, influencing cellular physiology with unprecedented spatiotemporal resolution. cm/s (Δ 0.87

Echocardiogram 40

Echocardiogram Bicuspid/Mitral Heart Rhythm Cardiac Function 40

Circulation

FEBRUARY 23, 2024

Circulation, Ahead of Print. BACKGROUND:Reparative macrophages play a crucial role in limiting excessive fibrosis and promoting cardiac repair after myocardial infarction (MI), highlighting the significance of enhancing their reparative phenotype for wound healing.

Myocardial Infarction 45

Myocardial Infarction Cardiac Function Biomarkers Heart Failure 45